# Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/histomolecular-resistance-mechanisms-to-first-line-osimertinib-in-egfr-mutated/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Assya Akli,Nicolas Girard,Vincent Fallet,G. Rousseau-Bussac,V. Gounant,S. Friard,Jean Trédaniel,C. Dujon,Marie Wislez,Boris Duchemann,Etienne Giroux‐Leprieur |
| Citations | 18 |
| DOI | 10.1007/s11523-022-00915-9 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4297874882 |
| PMID | 36129569 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Jean Trédaniel](https://scholariq.org/researchers/jean-tredaniel/)
- [Marie Wislez](https://scholariq.org/researchers/marie-wislez/)
- [V. Gounant](https://scholariq.org/researchers/v-gounant/)
- [Boris Duchemann](https://scholariq.org/researchers/boris-duchemann/)
- [Nicolas Girard](https://scholariq.org/researchers/nicolas-girard/)

## Paper journal

- [Targeted Oncology](https://scholariq.org/journals/targeted-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.